Clinical studies recruiting near Halle

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Observational Study Protocol: LIVER-R
Phase N/A · Research Site · AstraZeneca · NCT06252753 Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia
Phase 3 · Universitaetsklinikum Halle (Saale) AöR · Princess Maxima Center for Pediatric Oncology · NCT05327894 A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line
Phase 3 · Universitätsklinikum Halle ( Site 0604) · Merck Sharp & Dohme LLC · NCT06136559 This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in
Phase 3 · Krankenhaus Martha-Maria Halle-Dölau · Pfizer · NCT06758401 Niraparib vs Niraparib Plus Bevacizumab in Patients With Platinum/Taxane-based Chemotherapy in Advanced Ovarian Cancer
Phase 3 · Universitätsklinikum Halle · AGO Study Group · NCT05009082 A Non-interventional, Prospective Study With Benralizumab
Phase N/A · Research Site · AstraZeneca · NCT06422078 A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spe
Phase 2 · University of Halle · Relay Therapeutics, Inc. · NCT06789913 REscue Stenting With CREDO® Heal for Recanalisation After Unsuccessful Thrombectomy (RECHRUT)
Phase N/A · Diagnostische und Interventionelle Neuroradiologie, Universi · Acandis GmbH · NCT05345483 A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carbop
Phase 3 · Krankenhaus Martha-Maria Halle-Doelau gGmbH · Hoffmann-La Roche · NCT06793215 A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
Phase 2 · Studiengesellschaft Mitteldeutschland GmbH · Eli Lilly and Company · NCT07483099 Real-World Clinical Experience of Patients With Metastatic Castration-Resistant Prostate Cancer Treated With Olaparib +
Phase N/A · Research Site · AstraZeneca · NCT06380738 Endometrial Cancer Lymphadenectomy Trial
NA · Universitätsklinikum Halle/S., Universitätsklinik und Polikl · Philipps University Marburg · NCT03438474 Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS
Phase 3 · Krankenhaus Martha-Maria Halle-Dölau · Eli Lilly and Company · NCT06890598 International HIT-MED Registry (I-HIT-MED)
Phase N/A · University Hospital Halle/Saale · Universitätsklinikum Hamburg-Eppendorf · NCT02417324 Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcera
Phase 3 · Studiengesellschaft Mitteldeutschland GmbH · Eli Lilly and Company · NCT06937086 PROOFS-Registry - Premenopausal Women With Breast Cancer Optimally Treated With OFS
Phase N/A · Krankenhaus St. Elisabeth und St. Barbara Halle/Saale · Women's Cancer Study Group GmbH · NCT05792150 GMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding Diagnosis, Treatment and Outcome of
Phase N/A · Krankenhaus St. Elisabeth und St. Barbara Halle/Saale · Goethe University · NCT02872987 EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
Phase 3 · Universitätsklinikum Halle (Saale) AöR · Boehringer Ingelheim · NCT06531824 Early Catheter-directed Treatment of High Risk Pulmonary Embolism
NA · Universitätsklinikum Halle · Leipzig Heart Science gGmbH · NCT06672081 A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
Phase 2 · Universitaetsklinikum Halle ( Site 0902) · Merck Sharp & Dohme LLC · NCT06833073 A Comparison Study of Persistence of UPadacitinib vs. TNF-inhibitoRs In a German Real-world SettING
Phase N/A · Rheumapraxis Dr. Liebhaber /ID# 274888 · AbbVie · NCT06712628 NG004 in Spinal Cord Injury Patients
Phase 1 · Zentrum für Rückenmarkverletzte und Klinik für Orthopädie, B · NovaGo Therapeutics AG · NCT06817577 Treatment of Non-resectable Bile Duct Cancer with Radiofrequency Ablation or Photodynamic Therapy
Phase 4 · Site: Martin-Luther-Universitat Halle-Wittenberg, Universitä · University of Leipzig · NCT05551299 Real-world Experience With Lutetium Vipivotide Tetraxetan in Metastatic Castration Resistant Prostate Cancer
Phase N/A · Novartis Investigative Site · Novartis Pharmaceuticals · NCT06517719 A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS
Phase 3 · University Hospital Halle (Saale), Department of Internal Me · Takeda · NCT06499285 Venetoclax Plus Azacitidine Versus Intensive Chemotherapy for Fit Patients With Newly Diagnosed NPM1 Mutated AML
Phase 2 · Universitätsklinikum Halle · Technische Universität Dresden · NCT05904106 TTFields in General Routine Clinical Care in Patients With Pleural Mesothelioma Study
Phase N/A · Krankenhaus Martha-Maria Halle-Doelau · NovoCure Ltd. · NCT05538806 Adjusted High-dose Chemotherapy With Autologous Stem Cell Transplant vs. Conventional Immunochemotherapy in Elderly PCNS
Phase 3 · Universitätsklinikum Halle (Saale) · University Hospital Freiburg · NCT06830421 A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancre
Phase 3 · Investigative Site DE002 · Incyte Corporation · NCT07522073 Prospective WCD Post CABG Registry (CABG Registry)
Phase N/A · Universitätsklinikum Halle (Saale) · Zoll Medical Corporation · NCT06570902

Look up another city

Look up another condition